期刊
MOLECULAR THERAPY
卷 27, 期 2, 页码 442-455出版社
CELL PRESS
DOI: 10.1016/j.ymthe.2018.11.017
关键词
-
资金
- Flight Attendant Medical Research Institute (FAMRI) grant [CIA150086]
- American Lung Association [RG-305752]
- FAMRI grant [YFA130008]
Transforming growth factor beta (TGF-beta), signaling induced by cigarette smoke (CS), plays an important role in the progression of airway diseases, like chronic bronchitis associated with chronic obstructive pulmonary disease (COPD), and in smokers. Chronic bronchitis is characterized by reduced mucociliary clearance (MCC). Cystic fibrosis transmembrane conductance regulator (CFTR) plays an important role in normal MCC. TGF-beta and CS (via TGF-beta) promote acquired CFTR dysfunction by suppressing CFTR biogenesis and function. Understanding the mechanism by which CS promotes CFTR dysfunction can identify therapeutic leads to reverse CFTR suppression and rescue MCC. TGF-beta alters the micro-RNAome of primary human bronchial epithelium. TGF-beta and CS upregulate miR-145-5p expression to suppress CFTR and the CFTR modifier, SLC26A9. miR-145-5p upregulation with a concomitant CFTR and SLC26A9 suppression was validated in CS-exposed mouse models. While miR-145-5p antagonism rescued the effects of TGF-beta in bronchial epithelial cells following transfection, an aptamer to block TGF-beta signaling rescues CS- and TGF-beta-mediated suppression of CFTR biogenesis and function in the absence of any transfection reagent. These results demonstrate that miR-145-5p plays a significant role in acquired CFTR dysfunction by CS, and they validate a clinically feasible strategy for delivery by inhalation to locally modulate TGF-beta signaling in the airway and rescue CFTR biogenesis and function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据